Increasing the Supply of a Life-Saving Anti-TB Medicine

World TB Day

TB kills more people than any other single infectious disease. Learn how PQM – a public health program supported by USAID & implemented by USP - is helping to increase the global supply of quality-assured kanamycin, an essential TB drug.

Share

Exploring Continuous Manufacturing Technology and Applications in the Pharmaceutical Industry

Pharmaceutical continuous manufacturing

As more drug makers adopt pharmaceutical continuous manufacturing, new technological developments and operational demands are resulting from new partnerships among academic centers and industry leaders, particularly in the past two years.  To this goal, USP recently formalized collaborations with Center for Structured Organic Particulate Systems (C-SOPS), a leader in research on PCM. Learn more about the opportunities in this field.

Share

There is Room for Girls in Science

Girls in Science

I think girls everywhere would like to see the day when we do not talk about great women scientists but just great scientists. Being a woman shouldn’t make your achievements any more or less impressive ~ Serena Piervincenzi

Share

Building the Pipeline: African Women in Health and Science

African Women in Health and Science

Although women comprise a majority of the global health workforce, they are under-represented at the decision-making level of global policy and governance. This workforce pipeline challenge was a focus of recent remarks by the President of Mauritius, Her Excellency Ameenah Gurib-Fakim, during an event hosted by USP’s CePAT in Ghana to celebrate African women leaders in pharmacuetical regulatory affairs.

Share

Exploring the Promise and Challenges of Nanomedicines

Nanomedicines Opportunities and Challenges

Nanomedicine—the use of nanoscale materials and technologies to treat diseases at the molecular level—has shown promising results in patient care, particularly in oncology. While this potential has led to increased research, there are challenges surrounding nomenclature, characterization and environmental impact. Learn how you can collaborate with USP to help determine a path foward.

Share

3 Reasons Why USP Supports Pharmacist Healthcare Provider Status Legislation

Pharmacist Healthcare Provider Status Legislation

The bipartisan support for the Pharmacy and Medically Underserved Areas Enhancement Act demonstrates that legislators and policymakers recognize the value pharmacists bring to patients and the U.S. healthcare system. USP applauds this step and supports swift passage of this important legislation.

Share

Attacking Fake Medicines From All Sides

Attacking Fake Medicines

International Pharmaceutical Federation CEO Luc Besançon guest blogs about how to combat fake medicines proliferation.

Share

USP & India: Investing in Future through Pharmaceutical Expertise, Global Medicines Quality

USP and India Investing in Global Medicines Quality

USP and India's National Institutes for Pharmaceutical Education and Research work together to emphasize good-quality medicines and professional development.

Share

New USP Drug Classification System Proposed—Comment Now

Comment on USP Drug Classification System

Comment on USP's proposed Drug Classification System by December 5, 2016.

Share

Hug a Pharmacist

Hug a Pharmacist

Pharmacy experts explain the contemporary pharmacist's many roles. 

Share

Pages